Price $0.95 |
Market Cap
133.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
5.33
|
P/S
19.27
|
Dividend %
-
|
|
P/CF
4.2
|
P/FCF
-
|
Op. Cash Flow
-4.1K
|
FCF
-0.2
|
|
Op. Margin
-154.90%
|
Net Margin
-140.10%
|
ROE
-66.10%
|
ROI
-45.90%
|
|
ROA
-19.20%
|
EPS Growth
57.40%
|
Current Ratio
5.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Amneal Pharmaceuticals Inc (AMRX) | $5.81 | - | - | 2.02B | Strong Buy |
| Carecloud Inc (MTBC) | $7.60 | - | - | 119.6M | Strong Buy |
| Gilead Sciences, Inc. (GILD) | $66.38 | - | 4.30% | 81.21B | Strong Buy |
| Genesis Healthcare Inc (GENN) | $0.23 | - | - | 47.3M | Strong Buy |
| Eyenovia Inc (EYEN) | $5.31 | - | - | 127.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
